SCHEDULE 13D/A

Cosciens Biopharma Inc

Common stock, no par value · CUSIP: 22112H101

Event date: 2025-05-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Goodwood Fund

  Shares: 257,257.00 · Class: 8.2%

• Goodwood Inc.Reported CIK 0001297339

  Shares: 257,257.00 · Class: 8.2%

• Peter Puccetti

  Shares: 257,257.00 · Class: 8.2%

• Puccetti Funds Management Inc.

  Shares: 257,257.00 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.